These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38320033)

  • 1. Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19.
    McQuilten ZK; Venkatesh B; Jha V; Roberts J; Morpeth SC; Totterdell JA; McPhee GM; Abraham J; Bam N; Bandara M; Bangi AK; Barina LA; Basnet BK; Bhally H; Bhusal KR; Bogati U; Bowen AC; Burke AJ; Christopher DJ; Chunilal SD; Cochrane B; Curnow JL; Das SK; Dhungana A; Di Tanna GL; Dotel R; DSouza H; Dummer J; Dutta S; Foo H; Gilbey TL; Giles ML; Goli K; Gordon A; Gyanwali P; Haksar D; Hudson BJ; Jani MK; Jevaji PR; Jhawar S; Jindal A; John MJ; John M; John FB; John O; Jones M; Joshi RD; Kamath P; Kang G; Karki AR; Karmalkar AM; Kaur B; Koganti KC; Koshy JM; Krishnamurthy MS; Lau JS; Lewin SR; Lim LL; Marschner IC; Marsh JA; Maze MJ; McGree JM; McMahon JH; Medcalf RL; Merriman EG; Misal AP; Mora JM; Mudaliar VK; Nguyen V; O'Sullivan MV; Pant S; Pant P; Paterson DL; Price DJ; Rees MA; Robinson JO; Rogers BA; Samuel S; Sasadeusz J; Sharma D; Sharma PK; Shrestha R; Shrestha SK; Shrestha P; Shukla U; Shum O; Sommerville C; Spelman T; Sullivan RP; Thatavarthi U; Tran HA; Trask N; Whitehead CL; Mahar RK; Hammond NE; McFadyen JD; Snelling TL; Davis JS; Denholm JT; Tong SYC
    NEJM Evid; 2023 Feb; 2(2):EVIDoa2200293. PubMed ID: 38320033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    ; Bradbury CA; Lawler PR; Stanworth SJ; McVerry BJ; McQuilten Z; Higgins AM; Mouncey PR; Al-Beidh F; Rowan KM; Berry LR; Lorenzi E; Zarychanski R; Arabi YM; Annane D; Beane A; van Bentum-Puijk W; Bhimani Z; Bihari S; Bonten MJM; Brunkhorst FM; Buzgau A; Buxton M; Carrier M; Cheng AC; Cove M; Detry MA; Estcourt LJ; Fitzgerald M; Girard TD; Goligher EC; Goossens H; Haniffa R; Hills T; Huang DT; Horvat CM; Hunt BJ; Ichihara N; Lamontagne F; Leavis HL; Linstrum KM; Litton E; Marshall JC; McAuley DF; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Morpeth SC; Murthy S; Neal MD; Nichol AD; Parke RL; Parker JC; Reyes LF; Saito H; Santos MS; Saunders CT; Serpa-Neto A; Seymour CW; Shankar-Hari M; Singh V; Tolppa T; Turgeon AF; Turner AM; van de Veerdonk FL; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Derde LPG; Webb SA; Gordon AC
    JAMA; 2022 Apr; 327(13):1247-1259. PubMed ID: 35315874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
    ; ; ; Lawler PR; Goligher EC; Berger JS; Neal MD; McVerry BJ; Nicolau JC; Gong MN; Carrier M; Rosenson RS; Reynolds HR; Turgeon AF; Escobedo J; Huang DT; Bradbury CA; Houston BL; Kornblith LZ; Kumar A; Kahn SR; Cushman M; McQuilten Z; Slutsky AS; Kim KS; Gordon AC; Kirwan BA; Brooks MM; Higgins AM; Lewis RJ; Lorenzi E; Berry SM; Berry LR; Aday AW; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Costantini TW; de Brouwer S; Derde LPG; Detry MA; Duggal A; Džavík V; Effron MB; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Galanaud JP; Galen BT; Gandotra S; García-Madrona S; Girard TD; Godoy LC; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Hamburg NM; Haniffa R; Hanna G; Hanna N; Hegde SM; Hendrickson CM; Hite RD; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Hudock K; Hunt BJ; Husain M; Hyzy RC; Iyer VN; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski AL; King AJ; Knudson MM; Kornblith AE; Krishnan V; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Lima FG; Linstrum K; Litton E; Lopez-Sendon J; Lopez-Sendon Moreno JL; Lother SA; Malhotra S; Marcos M; Saud Marinez A; Marshall JC; Marten N; Matthay MA; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Moore SC; Morillo Guerrero R; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nunez-Garcia B; Pandey A; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pérez González YS; Pompilio M; Prekker ME; Quigley JG; Rost NS; Rowan K; Santos FO; Santos M; Olombrada Santos M; Satterwhite L; Saunders CT; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Shankar-Hari M; Sheehan JP; Singhal AB; Solvason D; Stanworth SJ; Tritschler T; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Wells BJ; Widmer RJ; Wilson JG; Yuriditsky E; Zampieri FG; Angus DC; McArthur CJ; Webb SA; Farkouh ME; Hochman JS; Zarychanski R
    N Engl J Med; 2021 Aug; 385(9):790-802. PubMed ID: 34351721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    ; ; ; Goligher EC; Bradbury CA; McVerry BJ; Lawler PR; Berger JS; Gong MN; Carrier M; Reynolds HR; Kumar A; Turgeon AF; Kornblith LZ; Kahn SR; Marshall JC; Kim KS; Houston BL; Derde LPG; Cushman M; Tritschler T; Angus DC; Godoy LC; McQuilten Z; Kirwan BA; Farkouh ME; Brooks MM; Lewis RJ; Berry LR; Lorenzi E; Gordon AC; Ahuja T; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Contreras A; Costantini TW; de Brouwer S; Detry MA; Duggal A; Džavík V; Effron MB; Eng HF; Escobedo J; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Froess JD; Fu Z; Galanaud JP; Galen BT; Gandotra S; Girard TD; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Haniffa R; Hegde SM; Hendrickson CM; Higgins AM; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Huang DT; Hudock K; Hunt BJ; Husain M; Hyzy RC; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski A; King AJ; Knudson MM; Kornblith AE; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Gallego Lima F; Linstrum K; Litton E; Lopez-Sendon J; Lother SA; Marten N; Saud Marinez A; Martinez M; Mateos Garcia E; Mavromichalis S; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nicolau JC; Nunez-Garcia B; Park JJ; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pompilio M; Quigley JG; Rosenson RS; Rost NS; Rowan K; Santos FO; Santos M; Santos MO; Satterwhite L; Saunders CT; Schreiber J; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Singhal AB; Slutsky AS; Solvason D; Stanworth SJ; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Widmer RJ; Wilson JG; Yuriditsky E; Zhong Y; Berry SM; McArthur CJ; Neal MD; Hochman JS; Webb SA; Zarychanski R
    N Engl J Med; 2021 Aug; 385(9):777-789. PubMed ID: 34351722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    Berger JS; Kornblith LZ; Gong MN; Reynolds HR; Cushman M; Cheng Y; McVerry BJ; Kim KS; Lopes RD; Atassi B; Berry S; Bochicchio G; de Oliveira Antunes M; Farkouh ME; Greenstein Y; Hade EM; Hudock K; Hyzy R; Khatri P; Kindzelski A; Kirwan BA; Baumann Kreuziger L; Lawler PR; Leifer E; Lopez-Sendon Moreno J; Lopez-Sendon J; Luther JF; Nigro Maia L; Quigley J; Sherwin R; Wahid L; Wilson J; Hochman JS; Neal MD;
    JAMA; 2022 Jan; 327(3):227-236. PubMed ID: 35040887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Trial of Nafamostat for Covid-19.
    Morpeth SC; Venkatesh B; Totterdell JA; McPhee GM; Mahar RK; Jones M; Bandara M; Barina LA; Basnet BK; Bowen AC; Burke AJ; Cochrane B; Denholm JT; Dhungana A; Dore GJ; Dotel R; Duffy E; Dummer J; Foo H; Gilbey TL; Hammond NE; Hudson BJ; Jha V; Jevaji PR; John O; Joshi R; Kang G; Kaur B; Kim S; Das SK; Lau JSY; Littleford R; Marsh JA; Marschner IC; Matthews G; Maze MJ; McArthur CJ; McFadyen JD; McMahon JH; McQuilten ZK; Molton J; Mora JM; Mudaliar V; Nguyen V; O'Sullivan MVN; Pant S; Park JE; Paterson DL; Price DJ; Raymond N; Rees MA; Robinson JO; Rogers BA; Ryu WS; Sasadeusz J; Shum O; Snelling TL; Sommerville C; Trask N; Lewin SR; Hills TE; Davis JS; Roberts JA; Tong SYC
    NEJM Evid; 2023 Nov; 2(11):EVIDoa2300132. PubMed ID: 38320527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19.
    Godoy LC; Neal MD; Goligher EC; Cushman M; Houston BL; Bradbury CA; McQuilten ZK; Tritschler T; Kahn SR; Berry LR; Lorenzi E; Jensen T; Higgins AM; Kornblith LZ; Berger JS; Gong MN; Paul JD; Castellucci LA; Le Gal G; Lother SA; Rosenson RS; Derde LPG; Kumar A; McVerry BJ; Nicolau JC; Leifer E; Escobedo J; Huang DT; Reynolds HR; Carrier M; Kim KS; Hunt BJ; Slutsky AS; Turgeon AF; Webb SA; McArthur CJ; Farkouh ME; Hochman JS; Zarychanski R; Lawler PR
    JACC Adv; 2024 Mar; 3(3):100780. PubMed ID: 38938844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.
    Smilowitz NR; Hade EM; Kornblith LZ; Castellucci LA; Cushman M; Farkouh M; Gong MN; Heath A; Hunt BJ; Kim KS; Kindzelski A; Lawler P; Leaf DE; Goligher E; Leifer ES; McVerry BJ; Reynolds HR; Zarychanski R; Hochman JS; Neal MD; Berger JS
    Res Pract Thromb Haemost; 2023 Aug; 7(6):102167. PubMed ID: 37727846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies.
    Pilia E; Belletti A; Fresilli S; Lee TC; Zangrillo A; Finco G; Landoni G;
    Lung; 2023 Apr; 201(2):135-147. PubMed ID: 36738324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
    Bohula EA; Berg DD; Lopes MS; Connors JM; Babar I; Barnett CF; Chaudhry SP; Chopra A; Ginete W; Ieong MH; Katz JN; Kim EY; Kuder JF; Mazza E; McLean D; Mosier JM; Moskowitz A; Murphy SA; O'Donoghue ML; Park JG; Prasad R; Ruff CT; Shahrour MN; Sinha SS; Wiviott SD; Van Diepen S; Zainea M; Baird-Zars V; Sabatine MS; Morrow DA;
    Circulation; 2022 Nov; 146(18):1344-1356. PubMed ID: 36036760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.
    Berger JS; Neal MD; Kornblith LZ; Gong MN; Reynolds HR; Cushman M; Althouse AD; Lawler PR; McVerry BJ; Kim KS; Baumann Kreuziger L; Solomon SD; Kosiborod MN; Berry SM; Bochicchio GV; Contoli M; Farkouh ME; Froess JD; Gandotra S; Greenstein Y; Hade EM; Hanna N; Hudock K; Hyzy RC; Ibáñez Estéllez F; Iovine N; Khanna AK; Khatri P; Kirwan BA; Kutcher ME; Leifer E; Lim G; Lopes RD; Lopez-Sendon JL; Luther JF; Nigro Maia L; Quigley JG; Wahid L; Wilson JG; Zarychanski R; Kindzelski A; Geraci MW; Hochman JS;
    JAMA Netw Open; 2023 May; 6(5):e2314428. PubMed ID: 37227729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    Goligher EC; Lawler PR; Jensen TP; Talisa V; Berry LR; Lorenzi E; McVerry BJ; Chang CH; Leifer E; Bradbury C; Berger J; Hunt BJ; Castellucci LA; Kornblith LZ; Gordon AC; McArthur C; Webb S; Hochman J; Neal MD; Zarychanski R; Berry S; Angus DC;
    JAMA; 2023 Apr; 329(13):1066-1077. PubMed ID: 36942550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
    ; Higgins AM; Berry LR; Lorenzi E; Murthy S; McQuilten Z; Mouncey PR; Al-Beidh F; Annane D; Arabi YM; Beane A; van Bentum-Puijk W; Bhimani Z; Bonten MJM; Bradbury CA; Brunkhorst FM; Burrell A; Buzgau A; Buxton M; Charles WN; Cove M; Detry MA; Estcourt LJ; Fagbodun EO; Fitzgerald M; Girard TD; Goligher EC; Goossens H; Haniffa R; Hills T; Horvat CM; Huang DT; Ichihara N; Lamontagne F; Marshall JC; McAuley DF; McGlothlin A; McGuinness SP; McVerry BJ; Neal MD; Nichol AD; Parke RL; Parker JC; Parry-Billings K; Peters SEC; Reyes LF; Rowan KM; Saito H; Santos MS; Saunders CT; Serpa-Neto A; Seymour CW; Shankar-Hari M; Stronach LM; Turgeon AF; Turner AM; van de Veerdonk FL; Zarychanski R; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Derde LPG; Gordon AC; Webb SA; Lawler PR
    JAMA; 2023 Jan; 329(1):39-51. PubMed ID: 36525245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin in Critically Ill Patients with Covid-19.
    ; Hills TE; Lorenzi E; Berry LR; Shyamsundar M; Al-Beidh F; Annane D; Arabi Y; Aryal D; Au C; Beane A; Bhimani Z; Bonten M; Bradbury CA; Brunkhorst FM; Burrell A; Buxton M; Calfee CS; Cecconi M; Cheng AC; Cove ME; Detry MA; Estcourt LJ; Fitzgerald M; Goligher EC; Goossens H; Green C; Haniffa R; Harrison DA; Hashmi M; Higgins AM; Horvat C; Huang DT; Ichihara N; Jayakumar D; Kruger PS; Lamontagne F; Lampro L; Lawler PR; Marshall JC; Mason AJ; McGlothlin A; McGuinness S; McQuilten ZK; McVerry BJ; Mouncey PR; Murthy S; Neal MD; Nichol AD; O'Kane CM; Parke RL; Parker JC; Rabindrarajan E; Reyes LF; Rowan KM; Saito H; Santos M; Saunders CT; Seymour CW; Shankar-Hari M; Sinha P; Thompson BT; Turgeon AF; Turner AM; van de Veerdonk F; Weis S; Young IS; Zarychanski R; Lewis RJ; McArthur CJ; Angus DC; Berry SM; Derde LPG; Webb SA; Gordon AC; McAuley DF
    N Engl J Med; 2023 Dec; 389(25):2341-2354. PubMed ID: 37888913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials.
    Ena J; Valls V
    Clin Exp Med; 2023 Aug; 23(4):1189-1196. PubMed ID: 36048371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
    Zuily S; Lefèvre B; Sanchez O; Empis de Vendin O; de Ciancio G; Arlet JB; Khider L; Terriat B; Greigert H; Robert CS; Louis G; Trinh-Duc A; Rispal P; Accassat S; Thiery G; Montani D; Azarian R; Meneveau N; Soudet S; Le Mao R; Maurier F; Le Moing V; Quéré I; Yelnik CM; Lefebvre N; Martinot M; Delrue M; Benhamou Y; Parent F; Roy PM; Presles E; Goehringer F; Mismetti P; Bertoletti L; Rossignol P; Couturaud F; Wahl D; Thilly N; Laporte S;
    EClinicalMedicine; 2023 Jun; 60():102031. PubMed ID: 37350990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.